Health Condition 1: L989- Disorder of the skin and subcutaneous tissue, unspecified Health Condition 2: L905- Scar conditions and fibrosis of skin
Conditions
Interventions
Intervention1: Botulinum toxin type A: It Can Decrease Tension At Scar Edges. Shrinking Of Enlarged Pores Is Added Benefit. 1:5 dilution of botulinum toxin with normal saline injected intradermally in
Sponsors
Shri Ram Murti Institute Of Medical Sciences
Eligibility
Inclusion criteria
Inclusion criteria: Patients giving written informed consent. Patient allowing to take photographs Patients having atrophic acne scars and wide facial pores. Patients having atrophic acne scars symmetrically on both sides of face.
Exclusion criteria
Exclusion criteria: Patients who are under treatment by topical or systemic retinoids during the last 3 months before the procedure will be excluded patients with a history of chemical peels, IPL, laser therapy in the last 3 months patients with neuromuscular diseases previous history of allergic reactions to botulinum toxin Previous history of allergy to lidocaine Breastfeeding females Pregnant females Patient not willing for regular follow up Patients with a history of bleeding disorders or patient on anticoagulant tor antiplatelet medication
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Comparison Of Efficacy And Safety Of Diluted Botulinum Toxin A VS PRP In Treatment Of Acne Scars And Wide Facial PoresTimepoint: Comparison Of Efficacy And Safety Of Diluted Botulinum Toxin A VS PRP In Treatment Of Acne Scars And Wide Facial Pores- Assessment done at interval of 4 weeks at each sitting and 8 weeks after 3rd sitting | — |
Secondary
| Measure | Time frame |
|---|---|
| Comparison Of Side Effects Of Both Treatment MethodsTimepoint: Evaluation At Baseline , At Every 4weeks, Then After 8 weeks of treatment completion , Total visits-4 | — |
Countries
India
Contacts
Public ContactDr Pratik Gahalaut
Shri Ram Murti Institute Of Medical Sciences
Outcome results
None listed